Recent SRZN News
- Surrozen Granted Patent from U.S. Patent and Trademark Office Directed to Antibody-Based Molecules Targeting Key Receptors in the Wnt Pathway • GlobeNewswire Inc. • 05/14/2025 12:30:01 PM
- Surrozen Reports First Quarter 2025 Financial Results and Provides Business Update • GlobeNewswire Inc. • 05/09/2025 08:05:08 PM
- Surrozen Provides Fourth Quarter and Full Year 2024 Financial Results and Business Updates • GlobeNewswire Inc. • 03/31/2025 08:05:16 PM
- Surrozen Announces an Oversubscribed $175 Million Private Placement of Securities to Focus on Selective Wnt Mimetic Therapeutics to Treat Serious Eye Diseases • GlobeNewswire Inc. • 03/24/2025 01:00:00 PM
- Surrozen to Present at Upcoming Healthcare Investor Conferences • GlobeNewswire Inc. • 11/06/2024 09:30:40 PM
- Surrozen Provides Third Quarter 2024 Financial Results and Business Update • GlobeNewswire Inc. • 11/06/2024 02:00:09 PM
- Surrozen and TCGFB, Inc. Announce Strategic Research Collaboration to Develop TGF-β Antibodies for Idiopathic Pulmonary Fibrosis • GlobeNewswire Inc. • 11/04/2024 01:30:55 PM
- Surrozen Earns $10 Million Milestone Payment in Retinal Diseases Collaboration • GlobeNewswire Inc. • 09/24/2024 12:30:23 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/12/2024 08:14:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/12/2024 08:08:28 PM
- Surrozen Provides Second Quarter 2024 Financial Results and Business Update • GlobeNewswire Inc. • 08/12/2024 08:05:09 PM
- Surrozen Publishes Study in ‘eLife’ Demonstrating the Promise of The Proprietary SWEETS Platform, a Unique Targeted Protein Degradation Technology, to Further Enhance Wnt Signaling • GlobeNewswire Inc. • 06/12/2024 12:30:36 PM
- Surrozen Presents Preliminary Results from Phase 1a Study of SZN-043 in Healthy Volunteers and Patients with a History of Liver Cirrhosis at the 2024 European Association for the Study of the Liver (EASL) in Milan • GlobeNewswire Inc. • 06/10/2024 12:30:01 PM
- Surrozen Initiates Dosing of First Patient in Phase 1b Clinical Trial of SZN-043 for Severe Alcohol-Associated Hepatitis • GlobeNewswire Inc. • 06/04/2024 12:30:16 PM
Authentic Events, LLC To Broadcast its First Pay Per View with Lingerie Fighting Championships on July 4th 2025 • AHRO • May 22, 2025 8:30 AM
Lingerie Fighting Championships Coming to the UK for July 4 & 6 Events • BOTY • May 19, 2025 10:00 AM
VAYK Projects to Report Over $400K Q1 Revenue • VAYK • May 15, 2025 9:00 AM
Veri Medtech (VRHI) Reaches $100 Million Revenue Milestone • VRHI • May 15, 2025 8:00 AM
Cannabix Enters Sales Distribution Agreement with Australian Distributor for BreathLogix Autonomous Alcohol Breathalyzer • BLO • May 14, 2025 8:51 AM
North Bay Resources Announces Resource Estimate of 474,000 ounces at Fran Gold Project, British Columbia • NBRI • May 13, 2025 9:58 AM